Stock Spotlight Archives - Page 156 of 383

WednesdaySep 29, 2021 2:35 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Leveraging Sapientus(TM) to Provide Clients with Big-Data Insights

FingerMotion (OTCQX: FNGR) is providing its clients with market insights as a growing number of Chinese consumers adopt online insurance products. According to the Google translation of a news release issued by Gold Investment Network, China’s online insurance premiums surpassed 290 billion yuan (US$44.8 million) last year (https://ibn.fm/7g2lO). The popularity of online premiums fueled a rapid surge in new economic activity within the country, which continues on an upward path as businesses turn to big data, cloud computing, artificial intelligence (“AI”), and other value-added technology to accelerate revenues. “FingerMotion has seen its revenues grow in consecutive reporting quarters during the…

WednesdaySep 29, 2021 1:47 pm

QualityStocksNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) Delivering Cutting-Edge Solutions for Retail and Consumer Products Industry

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, recently entered into a service contract with a subsidiary of a global leading retail brand (https://ibn.fm/7cclL). The Fortune 500 retail and consumer product company, with operations in over 80 countries worldwide, hopes to capitalize on Infobird’s intelligent quality inspection in a bid to significantly improve its customer service system. “Infobird is a software-as-a-service (‘SaaS’) provider, offering artificial intelligence (‘AI’)-powered customer engagement solutions for the Chinese market. Since it was founded in October 2001, the company has always sought to bring value to its clients with solutions to increase revenue,…

WednesdaySep 29, 2021 1:33 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Provides Improved Delivery for Wide Range of Product Formats

Lexaria Bioscience Corp. (NASDAQ: LEXX), an innovator of drug delivery methods, is improving the speed and efficiency of orally delivered fat-soluble active molecules and drugs with its patented technology. “DehydraTECH promotes a more effective, less expensive form of oral drug delivery evaluated thoroughly in vivo, in vitro and human clinical testing,” reads a recent article. “The DehydraTECH technology is suitable for use with a wide range of product formats. These include pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter (‘OTC’) capsules, pills, tablets, and oral suspensions. The technology was specifically designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients…

TuesdaySep 28, 2021 2:08 pm

QualityStocksNewsBreaks – DSG Global Inc. (DSGT), Imperium Set to Unveil Sagitta(TM) EV at Upcoming LA Auto Show

DSG Global (OTCQB: DSGT) and its subsidiary, Imperium Motors, have announced the planned launch of the Sagitta(TM) electric vehicle during the upcoming LA Auto Show slated to take place on Nov. 17, 2021. Imperium and California Mobility Works (“CMW”) are partnering to showcase the new three-wheel, four-passenger EV, which is expected to create quite a stir. As CMW’s primary Sagitta distribution partner, Imperium anticipates high demand for the vehicle as well as a need for downstream partners to meet that demand. A recent article quotes Rick Curtis of Imperium Motors as saying, “We are thrilled to team up with CMW…

TuesdaySep 28, 2021 1:08 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Continues to Revolutionize Hearing Care Landscape

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, is poised to empower consumers to take control of their hearing care. “InnerScope recently launched its hearing aids and related hearing products on FSAstore.com, HSAstore.com and WellDeservedHealth.com for the 70 million consumers enrolled in flexible spending accounts (‘FSA’), health saving accounts (‘HSA’) and employers’ health incentive programs. InnerScope partnered with the online retailer and industry leader in the U.S. tax-free healthcare market. Moreover, InnerScope’s hearing aids and related hearing products qualify as eligible products for FSA and HSA users and is the only…

MondaySep 27, 2021 1:07 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Eyes Commercial Plans to Become B2B Wholesale Supplier of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company based in British Columbia, Canada, is focused on advancing a pipeline of cannabinoid-based pharmaceutical drug candidates. The company is developing a proprietary cannabinoid synthesis manufacturing system known as IntegraSyn(TM), which is designed to advance rare and lesser-known cannabinoid production to commercial levels. A recent article discussing this quotes InMed CEO Eric A. Adams. “The next key milestone is to manufacture our first large-scale batch through a pharma-grade-ready process in the coming months. We will continue to optimize the process and scale up the IntegraSyn process into larger vessels,” Adams said in a recent…

MondaySep 27, 2021 12:52 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes First Step in European Expansion Plan

Flora Growth Corp. (NASDAQ: FLGC) recently closed a €2 million investment in Hoshi International Inc., a fully integrated cannabis company, and uniquely positioned to become the leading provider of cannabis and derivative products for the budding European market. With the investment, Flora is set to capitalize on Hoshi’s strong European presence as well as leverage its technical know-how and understanding of its European market to not only expand its reach but also obtain its European Union Good Manufacturing Practices (“EU-GMP”) certification. A recent article reads, “Flora hopes to capitalize on Hoshi’s understanding of and presence within the European market to…

MondaySep 27, 2021 11:56 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Working to Bring Psychedelic Treatments Closer to the People

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is contributing to the ongoing conversation around the use of psychedelics in the field of medicine, thereby stamping its position as a leader in the psychedelic renaissance. This follows efforts by the scientific community in the 21st century to prove the potential of psychedelics to rewire or repair circuits in the brain. Specifically, Tryp is bringing light to psilocybin usage in diseases with high unmet needs, including chronic pain, through its Psilocybin-For Neuropsychiatric Disorders (TM) (“PFN”) program. “With its three strategic initiatives — develop, protect and monetize — Tryp remains committed to utilizing FDA’s…

MondaySep 27, 2021 11:46 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Spotlights Companies in Burgeoning EdTech Space at Inaugural Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, brought together some of the stars within the education technology (“EdTech”) market in the first-ever Sequire EdTech Conference. The event featured prominent virtual work and remote learning companies and touched multiple value points for SRAX by featuring a burgeoning industry as a key opinion leader, showing off its platform to potential clients and investors and spotlighting public companies in the EdTech space. With the fall season expected to again be challenging for schools following the prominence of the…

FridaySep 24, 2021 2:08 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enhancing Performance of Antiviral Drugs, CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX) is making significant progress in advancing its patented DehydraTECH(TM) drug delivery technology. Lexaria recently reviewed its successful 2021 antiviral drug program. “The company has progressed significantly in evidencing that DehydraTECH can sufficiently enhance the usable fraction of known antiviral drugs that reach the bloodstream to safely and more effectively do what they are designed to accomplish,” reads a recent article. In addition to the antiviral program, Lexaria is also focused on another applied R&D program — hypertension. On July 29, it released partial results from a human clinical study, HYPER-H21-1, evaluating DehydraTECH-processed cannabidiol (“CBD”) for…

Site Search

Company Search

Category: Stock Spotlight